-
(2S)-1-(2-{[(2S)-1-acetylpyrrolidin-2-yl]formamido}acetyl)pyrrolidine-2-carboxylic acid trifluoroacetic acid hydrate
-
ChemBase ID:
155024
-
Molecular Formular:
C16H24F3N3O8
-
Molecular Mass:
443.3722696
-
Monoisotopic Mass:
443.1515494
-
SMILES and InChIs
SMILES:
CC(=O)N1CCC[C@H]1C(=O)NCC(=O)N1CCC[C@H]1C(=O)O.C(=O)(C(F)(F)F)O.O
Canonical SMILES:
OC(=O)C(F)(F)F.O=C(N1CCC[C@H]1C(=O)O)CNC(=O)[C@@H]1CCCN1C(=O)C.O
InChI:
InChI=1S/C14H21N3O5.C2HF3O2.H2O/c1-9(18)16-6-2-4-10(16)13(20)15-8-12(19)17-7-3-5-11(17)14(21)22;3-2(4,5)1(6)7;/h10-11H,2-8H2,1H3,(H,15,20)(H,21,22);(H,6,7);1H2/t10-,11-;;/m0../s1
InChIKey:
UCOFOXNKITYGTK-ULEGLUPFSA-N
-
Cite this record
CBID:155024 http://www.chembase.cn/molecule-155024.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
(2S)-1-(2-{[(2S)-1-acetylpyrrolidin-2-yl]formamido}acetyl)pyrrolidine-2-carboxylic acid trifluoroacetic acid hydrate
|
|
|
IUPAC Traditional name
|
(2S)-1-(2-{[(2S)-1-acetylpyrrolidin-2-yl]formamido}acetyl)pyrrolidine-2-carboxylic acid trifluoroacetic acid hydrate
|
|
|
Synonyms
|
1-Acetyl-L-prolylglycyl-L-proline
|
Acetyl Pro-Gly-Pro
|
Acetyl-proline-glycine-proline
|
N-α-PGP
|
acPGP
|
Ac-PGP trifluoroacetate salt hydrate
|
|
|
CAS Number
|
|
MDL Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
3.5801616
|
H Acceptors
|
5
|
H Donor
|
2
|
LogD (pH = 5.5)
|
-3.7708352
|
LogD (pH = 7.4)
|
-5.2062016
|
Log P
|
-1.8563358
|
Molar Refractivity
|
75.4202 cm3
|
Polarizability
|
29.383287 Å3
|
Polar Surface Area
|
107.02 Å2
|
Rotatable Bonds
|
5
|
Lipinski's Rule of Five
|
true
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
A2112
|
Biochem/physiol Actions N-acetyl Proline-Glycine-Proline (ac-PGP) is a potent and selective neutrophil chemoattractant. It is generated enzymatically from extracellular matrix proteins such as collagen. PGP is generated from native collagen by the action of matrix metalloproteinase-8 (MMP-8) and/or MMP-9, followed by a secondary cleavage by prolyl endopeptidase (PE). N-terminal acetylation of PGP (Ac-PGP) occurs through an unknown mechanism. Both PGP and AcPGP are considered biomarkers and possible therapeutic targets for chronic obstructive pulmonary disease (COPD) and may also be markers for acute pulmonary exacerbation in Cystic Fibrosis. |
PATENTS
PATENTS
PubChem Patent
Google Patent